Pharma companies are commercial centric. The motivation for GSK is to create a social good brand in the world of Pharma while bringing their scientific and manufacturing expertise to cure preventable diseases. For Save the Children, partnering with a multinational company increases their credibility and opens the door to explore more advanced partnerships.
GSK Motivation to scale-up the use of their medicine and to increase the awareness about the medicine benefit and Save th Children is getting donations-in-kind and saving funds and other resources like distribution cost by getting benefit from the existing supply-chain infrastructure of GSK
Their main motivation might have been to improve effectiveness of their individual responses to a global challenge thanks to the complementarity of their skills and assets (hence widening and deepening their impact). In this partnership were clearly identified the respective capabilities
and roles of both partners.
They could both gain from combining GSK’s scientific and manufacturing expertise with Save the Children’s on-the-ground experience. Save the Children could find a fit-for-purpose partner to address needs that they have identified on the ground while GSK is developping a needed product that will finds its way in the market (Basically a free market research study for them).
They both were looking for new ways to help bring down the number of children dying from preventable and treatable diseases, but they had different specific interests.